US Stock MarketDetailed Quotes

SNDX Syndax Pharmaceuticals

Watchlist
  • 16.520
  • +0.020+0.12%
Trading Nov 27 10:31 ET
1.41BMarket Cap-4538P/E (TTM)

Syndax Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Syndax Pharmaceuticals Q3 2024 Earnings Date

Currency：USDNov 5, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
8.40M
12.50M
+4.10M
Beat Est.
--
--
+48.83%
EPS
-1.03
-0.98
+0.05
Beat Est.
-40.72%
-34.25%
+4.59%
Analyst Rating
Strong Buy

Nov 21, 2024

Syndax Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 5 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 16.142M--
--2024/Q4-- / 115.226M--
Nov 5, 20242024/Q312.500M / 8.399M--
Aug 1, 20242024/Q23.500M / 0.000--
May 8, 20242024/Q10.000 / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 16.142M--
--2024/Q4-- / 115.226M--
Nov 5, 20242024/Q312.500M / 8.399M--
Aug 1, 20242024/Q23.500M / 0.000--
May 8, 20242024/Q10.000 / 0.000--

Unlock Free Earnings Estimates

Syndax Pharmaceuticals Earnings Reports

  • Syndax Pharmaceuticals | 8-K: Syndax Reports Third Quarter 2024 Financial Results and Provides Business Update

    Nov 5 16:08 ET

  • Syndax Pharmaceuticals | 10-Q: Q3 2024 Earnings Report

    Nov 5 16:06 ET

  • Syndax Pharmaceuticals | 8-K: Syndax Reports Second Quarter 2024 Financial Results and Provides Clinical and Business Update

    Aug 1 16:09 ET

  • Syndax Pharmaceuticals | 10-Q: Q2 2024 Earnings Report

    Aug 1 16:06 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Nov 21, 2024

    Strong Buy

    • Buy

      92.86%

    • Hold

      7.14%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data